Remove Compound Screening Remove Pharma Companies Remove Pharmaceutical Companies Remove Treatment
article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

Research into HIV blossomed throughout 2022, with ViiV Healthcare’s combination therapy for HIV-1 gaining approval in Japan; and research moving forward towards a one-time treatment for HIV as well as a vaccine. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.